| P50 | author | Jaeseung Kang | Q47683625 |
| | Min Whan Jung | Q86026513 |
| P2093 | author name string | Eunjoon Kim | |
| | Hanwool Park | |
| | Jeonghoon Choi | |
| | Myoung-Hwan Kim | |
| | Yong Chul Bae | |
| | Dongsoo Lee | |
| | Haram Park | |
| | Ryunhee Kim | |
| | Jong Won Lee | |
| | Yi Sul Cho | |
| | Daesoo Kim | |
| | Seungjoon Lee | |
| | Su Yeon Choi | |
| | Woosuk Chung | |
| | Yeonsoo Choi | |
| | Eunee Lee | |
| | Sae-Geun Park | |
| | Issac Rhim | |
| P2860 | cites work | Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development | Q22010598 |
| | Neuroligins and neurexins link synaptic function to cognitive disease | Q22251092 |
| | Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism | Q24307957 |
| | Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function | Q24338263 |
| | Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function | Q26269895 |
| | The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses | Q28142887 |
| | The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity | Q28509086 |
| | Deletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviors | Q28512821 |
| | ProSAP/Shank postsynaptic density proteins interact with insulin receptor tyrosine kinase substrate IRSp53 | Q28579738 |
| | Regulation of dendritic spine morphogenesis by insulin receptor substrate 53, a downstream effector of Rac1 and Cdc42 small GTPases | Q28580747 |
| | In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine). | Q44523578 |
| | Are NMDA receptor antagonists beneficial in the treatment of schizophrenia? | Q44650440 |
| | Distinct triggering and expression mechanisms underlie LTD of AMPA and NMDA synaptic responses. | Q45976114 |
| | Enhanced NMDA receptor-mediated synaptic transmission, enhanced long-term potentiation, and impaired learning and memory in mice lacking IRSp53. | Q46133242 |
| | Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. | Q46290655 |
| | Case-control study of six genes asymmetrically expressed in the two cerebral hemispheres: association of BAIAP2 with attention-deficit/hyperactivity disorder | Q47443921 |
| | Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems | Q48242363 |
| | Disruption of dentate gyrus blocks effect of visual input on spatial firing of CA1 neurons | Q48369968 |
| | Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: differential attachment of NMDA versus AMPA receptors. | Q48493391 |
| | Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. | Q48954065 |
| | Association study of six candidate genes asymmetrically expressed in the two cerebral hemispheres suggests the involvement of BAIAP2 in autism. | Q50302037 |
| | Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. | Q53574041 |
| | Fragile X syndrome: From protein function to therapy. | Q54782597 |
| | Postsynaptic distribution of IRSp53 in spiny excitatory and inhibitory neurons | Q28583499 |
| | Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality | Q28585096 |
| | Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders | Q29394511 |
| | Autism-like behavioral phenotypes in BTBR T+tf/J mice | Q29615512 |
| | Neocortical excitation/inhibition balance in information processing and social dysfunction | Q29616196 |
| | Dendritic organization in the neurons of the visual and motor cortices of the cat | Q29616515 |
| | NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders | Q29617936 |
| | The postsynaptic architecture of excitatory synapses: a more quantitative view | Q29617941 |
| | Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits | Q29618411 |
| | Behavioural phenotyping assays for mouse models of autism | Q29618414 |
| | Insulin receptor substrate of 53 kDa links postsynaptic shank to PSD-95. | Q30163939 |
| | Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data | Q30580986 |
| | Glutamate and schizophrenia: beyond the dopamine hypothesis | Q33996803 |
| | Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders | Q34024856 |
| | Memantine: a review of possible uses in child and adolescent psychiatry | Q34344303 |
| | Automated apparatus for quantitation of social approach behaviors in mice. | Q34345417 |
| | De novo mutations in schizophrenia implicate synaptic networks | Q34540372 |
| | Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses | Q34630019 |
| | Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. | Q35038897 |
| | Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities | Q35765423 |
| | Social approach and repetitive behavior in eleven inbred mouse strains | Q36740025 |
| | IRSp53: crossing the road of membrane and actin dynamics in the formation of membrane protrusions | Q37063714 |
| | Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy | Q37143121 |
| | BAIAP2 exhibits association to childhood ADHD especially predominantly inattentive subtype in Chinese Han subjects | Q37479742 |
| | The medial prefrontal cortex and integration in autism | Q37555867 |
| | Ultrastructure of synapses in the mammalian brain | Q37987406 |
| | Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders. | Q38006055 |
| | Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders | Q38053656 |
| | Activity-dependent neuronal signalling and autism spectrum disorder | Q38074584 |
| | Modeling autism by SHANK gene mutations in mice | Q38098737 |
| | The translation of translational control by FMRP: therapeutic targets for FXS. | Q38098906 |
| | Progress toward treatments for synaptic defects in autism | Q38112617 |
| | The genetic landscapes of autism spectrum disorders | Q38123219 |
| | Attention deficit hyperactivity disorder and N-methyl-D-aspartate (NMDA) dysregulation | Q38177353 |
| | Neurobiology of autism gene products: towards pathogenesis and drug targets. | Q38178068 |
| | Motor and cognitive stereotypies in the BTBR T+tf/J mouse model of autism | Q42140053 |
| | Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1. | Q43657512 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 435-443 | |
| P577 | publication date | 2015-01-26 | |
| P1433 | published in | Nature Neuroscience | Q1535359 |
| P1476 | title | Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression | |
| P478 | volume | 18 | |